Product Reports Resources Pricing Login Book a demo

Lucis

Health Tech & Medtech · Paris, France · Founded 2023

Formerly Zero Health, focus on proactive healthcare, prioritizing prevention rather than reactive care, with a system that emphasizes maintaining health MoreLess

Lucis is a preventive healthcare service that translates regular blood testing into actionable, personalized insights to help individuals extend their healthspan. Founded in 2024 in Paris by Maxime Berthelot (CEO), Baptiste Debever, and Max Guerois, the company aims to shift the healthcare paradigm from reactive treatment to proactive, data-driven prevention. The founding team's motivation stemmed from personal experiences, including a relative's death from a condition that could have been detected earlier.

The company operates on a subscription-based, business-to-consumer (B2C) model. Members undergo regular blood draws at one of Lucis's over 400 partner laboratories across Europe, including in France, the UK, Ireland, and Portugal. The service analyzes more than 180 biomarkers related to cardiometabolic health, hormones, inflammation, liver and kidney function, and micronutrients. This comprehensive panel provides a structured view of a person's health, aiming to identify imbalances and early signals associated with chronic diseases. The company explicitly positions itself as a preventive and educational tool, not a replacement for medical consultation or diagnosis.

Lucis combines artificial intelligence with review by a multidisciplinary medical team to interpret the test results. Instead of a static report, users receive access to a dynamic dashboard that tracks their data over time and a prioritized action plan. This plan is built around five pillars: nutrition, supplements, physical activity, sleep/recovery, and mental health. The platform is designed to empower individuals to take ownership of their health by providing clear guidance before symptoms appear.

In late 2025, Lucis secured an $8.5 million seed funding round led by General Catalyst, with participation from Y Combinator, Kima Ventures, and others. This capital is intended to accelerate the company's expansion in its existing markets and into new ones, grow its network of partner labs and physicians, and further develop its AI-powered platform. Since its launch, Lucis has served over 3,000 customers and conducted more than 500,000 clinical tests.

Keywords: preventive healthcare, blood testing analysis, healthspan extension, AI health platform, personalized health insights, biomarker tracking, proactive health, chronic disease prevention, longevity, nutrition guidance, Maxime Berthelot, Baptiste Debever, General Catalyst, Y Combinator, European healthtech, subscription health, B2C health, wellness monitoring, data-driven health, preventative medicine

Company overview

Lucis company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2023
Headquarters
Paris, France
Employees
36
Open positions
None listed
Dealroom signal
89.0
client focusb2csub industryHealth Platformbusiness modelSaaSindustryHealthsectorYC X25sectorobservatoire healthtech

Valuation & funding

Lucis funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC May 2026 $20M $80M Y Combinator · General Catalyst · Singular
EARLY VCEquity / VC Dec 2025 $8.5M $34M Motier Ventures · General Catalyst · Kima Ventures · Y Combinator
SEEDEquity / VC May 2025 $125K $500K Y Combinator
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 37
2025 22
2024 10
2023 2
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Lucis website traffic

Latest recorded traffic for Lucis is 44K monthly website visits, down 41.3% over the last three months. Lucis's team grew 63.6% over the past year.

Latest monthly visits44K 3-month web change-41.3% 1-year team growth+63.6%
Monthly website visits33 observations · Nov 2023–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Lucis compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Lucis's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Lucis's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 7 investors entered at this stage
General Catalyst
Motier Ventures
Kima Ventures
Stake Capital
Source Ventures
199 Ventures
Singular
Other known 1 additional known investor
Maiora Ventures

Global footprint

Where Lucis has talent and traffic

Workforce by country
🇫🇷 France · Paris HQ
Book a demo for the full country breakdown

In the news

Latest news about Lucis

Recent press, funding announcements, and product moves mentioning Lucis — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Lucis

An AI-synthesized read of the highest-engagement posts about Lucis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lucis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.